Commission Regulation (EU) 2017/171 of 30 January 2017 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, azoxystrobin, cyantraniliprole, cyflufenamid, cyproconazole, diethofencarb, dithiocarbamates, fluazifop-P, fluopyram, haloxyfop, isofetamid, metalaxyl, prohexadione, propaquizafop, pyrimethanil, Trichoderma atroviride strain SC1 and zoxamide in or on certain products
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XII Foodstuffs
Joint committee decision (JCD)
141/2017 In force in the EEA
Yes Legal documents
Commission Regulation (EU) 2017/171 of 30 January 2017 amending Annexes II, III and IV to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for aminopyralid, azoxystrobin, cyantraniliprole, cyflufenamid, cyproconazole, diethofencarb, dithiocarbamates, fluazifop-P, fluopyram, haloxyfop, isofetamid, metalaxyl, prohexadione, propaquizafop, pyrimethanil, Trichoderma atroviride strain SC1 and zoxamide in or on certain products
Reglugerð framkvæmdastjórnarinnar (ESB) 2017/171 frá 30. janúar 2017 um breytingu á II. III. og IV. viðauka við reglugerð Evrópuþingsins og ráðsins (EB) nr. 396/2005 að því er varðar hámarksgildi leifa fyrir amínópýralíð, asoxýstróbín, sýantranilípról, sýflúfenamíð, sýprókónasól, díetófenkarb, díþíókarbamöt, flúasífóp-P, flúópýram, haloxýfóp, ísófetamíð, metalaxýl, próhexadíón, própakvisafóp, pýrimetaníl, Trichoderma atroviride af stofni SC1 og soxamíð í eða á tilteknum afurðum
Verordnung (EU) 2017/171 der Kommission vom 30. Januar 2017 zur Änderung der Anhänge II, III und IV der Verordnung (EG) Nr. 396/2005 des Europäischen Parlaments und des Rates hinsichtlich der Rückstandshöchstgehalte für Aminopyralid, Azoxystrobin, Cyantraniliprol, Cyflufenamid, Cyproconazol, Diethofencarb, Dithiocarbamate, Fluazifop-P, Fluopyram, Haloxyfop, Isofetamid, Metalaxyl, Prohexadion, Propaquizafop, Pyrimethanil, Trichoderma atroviride Stamm SC1 und Zoxamid in oder auf bestimmten Erzeugnissen
Kommisjonsforordning (EU) 2017/171 av 30. januar 2017 om endring av vedlegg II, III og IV til europaparlaments- og rådsforordning (EF) nr. 396/2005 med hensyn til grenseverdier for rester av aminopyralid, azoksystrobin, cyantraniliprol, cyflufenamid, cyprokonazol, dietofenkarb, ditiokarbamater, fluazifop-P, fluopyram, haloksyfop, isofetamid, metalaksyl, proheksadion, propakvizafop, pyrimetanil, Trichoderma atroviride stamme SC1 og zoksamid i eller på visse produkter
History
08.07.2017
Adopted JCD confirmed entry into force date
08.07.2017
Compliance date in the EEA
07.07.2017
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
31.05.2017
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
30.01.2017
Adoption date in the EU
19.01.2017
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.